PAR PHARMACEUTICAL

PAR Pharmaceutical Company Introduction:

Please note that PAR Pharmaceutical is primarily a United States-based company, a subsidiary of Endo International plc, headquartered in Parsippany, New Jersey, USA. It is not an Indian company.

Regarding its nature of business, PAR Pharmaceutical is a manufacturer (factory). The company specializes in the development, manufacturing, and marketing of generic pharmaceutical products across a wide range of therapeutic areas. While they engage in the sale and distribution of their products, their core business involves the production of these pharmaceuticals. They are a significant player in the US generic drug market.

PAR Pharmaceutical is a United States-based generic pharmaceutical company and a subsidiary of Endo International. There is no specific 'PAR Pharmaceutical company in India' that manufactures or primarily sells products directly under that name within India.

The products manufactured and sold by PAR Pharmaceutical are predominantly for the United States market. These include a broad range of generic prescription medications across various therapeutic categories. While specific product lists are extensive and subject to change due to the nature of generic approvals and market dynamics, their offerings generally cover:

Central Nervous System (CNS) medications

Oncology products

Injectable products

Cardiovascular drugs

Anti-infectives

Gastroenterology treatments

Ophthalmology products

Women's Health medications

Dermatology products

Pain management medications

Examples of active pharmaceutical ingredients (APIs) that PAR Pharmaceutical has developed and marketed as generic versions include:

Amphetamine Sulfate

Methylphenidate Hydrochloride

Oxycodone Hydrochloride

Sumatriptan Succinate

Metoprolol Succinate

Gabapentin

Venlafaxine Hydrochloride

Divalproex Sodium

Cyclosporine

Fentanyl Citrate

Buprenorphine Hydrochloride and Naloxone Hydrochloride